FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shilpa Chokshi

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Physiology

Anatomy

CD4-Positive T-Lymphocytes

Concepts & Ideas

Co-author Network

Publications

TOP 3
U M Warshow; Shilpa Chokshi; D Hegazy; Edward Kaminski; A Riva; P H Thurairajah; Matthew E Cramp
Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.
Sandra Phillips; Shilpa Chokshi; Antonio Riva; Alexander Evans; Roger Williams; Nikolai Naoumov
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Ioannis Pachiadakis; Shilpa Chokshi; Helen Cooksley; Dimitrios Farmakiotis; Christoph Sarrazin; Stefan Zeuzem; Tomasz I Michalak; Nikolai Naoumov
Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shilpa Chokshi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: U M Warshow; Shilpa Chokshi; D Hegazy; Edward Kaminski; A Riva; P H Thurairajah; Matthew E Cramp
Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.
Journal of viral hepatitis 2012;19(7):501-8.
2010: Sandra Phillips; Shilpa Chokshi; Antonio Riva; Alexander Evans; Roger Williams; Nikolai Naoumov
CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(1):287-95.
2009: Ioannis Pachiadakis; Shilpa Chokshi; Helen Cooksley; Dimitrios Farmakiotis; Christoph Sarrazin; Stefan Zeuzem; Tomasz I Michalak; Nikolai Naoumov
Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions.
Clinical immunology (Orlando, Fla.) 2009;131(3):415-25.
2008: Alexander Evans; Antonio Riva; Helen Cooksley; Sandra Phillips; Smrithi Puranik; Amit Nathwani; Sara Brett; Shilpa Chokshi; Nikolai Naoumov
Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion.
Hepatology (Baltimore, Md.) 2008;48(3):759-69.
2008: Sandra Proto; John A Taylor; Shilpa Chokshi; Naveenan Navaratnam; Nikolai Naoumov
APOBEC and iNOS are not the main intracellular effectors of IFN-gamma-mediated inactivation of Hepatitis B virus replication.
Antiviral research 2008;78(3):260-7.
2008: Helen Cooksley; Shilpa Chokshi; Yafit Maayan; Heiner Wedemeyer; Pietro Andreone; Richard Gilson; Thomas Warnes; Simona Paganin; Fabien Zoulim; David Frederick; Avidan U Neumann; Carol L Brosgart; Nikolai Naoumov
Hepatitis B virus e antigen loss during adefovir dipivoxil therapy is associated with enhanced virus-specific CD4+ T-cell reactivity.
Antimicrobial agents and chemotherapy 2008;52(1):312-20.
2005: Eirini I Rigopoulou; Deepak Suri; Shilpa Chokshi; Ivana Mullerova; Steven Rice; Richard S Tedder; Roger Williams; Nikolai Naoumov
Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity.
Hepatology (Baltimore, Md.) 2005;42(5):1028-36.
2005: Kwok H Tang; Eva Herrmann; Helen Cooksley; Nick Tatman; Shilpa Chokshi; Roger Williams; Stefan Zeuzem; Nikolai Naoumov
Relationship between early HCV kinetics and T-cell reactivity in chronic hepatitis C genotype 1 during peginterferon and ribavirin therapy.
Journal of hepatology 2005;43(5):776-82.
2004: Shilpa Chokshi; Nikolai Naoumov
In vitro analysis of hepatitis B virus specific CD4+ T cells.
Methods in molecular medicine 2004;96():97-109.
2000: Matthew E Cramp; Siegbert Rossol; Shilpa Chokshi; P Carucci; Roger Williams; Nikolai Naoumov
Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Gastroenterology 2000;118(2):346-55.
1999: Matthew E Cramp; P Carucci; Siegbert Rossol; Shilpa Chokshi; Geert Maertens; Roger Williams; Nikolai Naoumov
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia.
Gut 1999;44(3):424-9.
1997: I Nagata; N Tzampouras; Shilpa Chokshi; Nikolai Naoumov; P Cheeseman; H M Smith; A J Baker; Roger Williams; Giorgina Mieli-Vergani
Hepatitis GB virus-C/hepatitis G virus infection in liver disease.
Archives of disease in childhood 1997;77(3):223-6.
1997: Nikolai Naoumov; Shilpa Chokshi; E Metivier; Geert Maertens; P J Johnson; Roger Williams
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis.
Journal of hepatology 1997;27(2):331-6.
1995: G Marinos; Francesco Torre; Shilpa Chokshi; M Hussain; B E Clarke; D J Rowlands; A L Eddleston; Nikolai Naoumov; Roger Williams
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus.
Hepatology (Baltimore, Md.) 1995;22(4 Pt 1):1040-9.
1995: Nikolai Naoumov; Mark Thomas; Andrew L Mason; Shilpa Chokshi; C J Bodicky; F Farzaneh; Roger Williams; Robert P Perrillo
Genomic variations in the hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.
Gastroenterology 1995;108(2):505-14.